17:23 IST
BSE
Other Announcement
Vista Pharmaceuticals Other Announcement
Vista Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Vista Pharmaceuticals Ltd
- Share price
- ₹6.40
- Market cap
- ₹39.39 Cr
- Revenue (annual)
- ₹5.40 Cr
- Net profit (annual)
- ₹-12.06 Cr
- P/E (TTM)
- -3.4×Sector 47.4×
- Promoter holding
- 21.19%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 3Other Announcement 2Board Meeting Date 2Management Change 1Debt & Borrowing 1
Time
2 announcements with these filters
15:29 IST
BSE
Other Announcement
Vista Pharmaceuticals Other Announcement
Vista Pharmaceuticals Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with no material deviations.